Web Results

caselaw.findlaw.com/ca-court-of-appeal/1114587.html

Case opinion for CA Court of Appeal CONTE v. WYETH INC. Read the Court's full decision on FindLaw.

www.oyez.org/cases/2010/09-152

Oct 12, 2010 ... Two hours after Hannah Bruesewitz received her six-month diphtheria, tetanus and pertussis vaccine in 1992, she started developing seizures ...

www.supremecourt.gov/opinions/10pdf/09-152.pdf

Feb 22, 2011 ... Syllabus. BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC.,. ET AL. CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR.

repository.law.miami.edu/cgi/viewcontent.cgi?article=1711&context=umlr

Oct 1, 1997 ... regarding earlier drafts of the article, and Dr. Barbara Chesney for her help in clarifying questions and her ..... courts, following a rule articulated in Silver Chrysler Plymouth, Inc. v. ...... Wyeth Lab., Inc., 127 F.R.D. 653 (E. D. Pa.

www.lexislegalnews.com/articles/20144/multiplaintiff-amiodarone-cases-remanded-federal-question-jurisdiction-lacking

Sep 6, 2017 ... Eon Labs, Inc., et al., No. 17-2609, John W. Blackford, et al. v. Wyeth Pharmaceutical, Inc., et al., No. 17-3825, N.D. Calif., 2017 U.S. Dist.

www.leagle.com/decisions/browse/series/volume/131%20%20%20%20%20S.Ct.

... v. WYETH INC., Supreme Court of United States. 131 S.Ct. 52 ... 131 S.Ct. 57 - BRITISH AMERICAN TOBACCO LTD. v. U.S. ...... 131 S.Ct. 908 - CHESNEY v.

www.ncbi.nlm.nih.gov/pmc/articles/PMC1550709

Laurel K. Leslie, MD,* Thomas B. Newman, MD, MPH,‡ P. Joan Chesney, MD,§ and ..... Luvox (fluvoxamine)/Solvay, 1994, 1997, Solvay Pharmaceuticals, Inc, ... First, Wyeth, the producers of venlafaxine, addressed the FDA's mandate by ..... in childhood depression: systematic review of published versus unpublished data.

www.geisinger.org/-/media/OneGeisinger/pdfs/ghs/about-geisinger/foundation/Geisinger-Gifts-Grants-Donor-Report-FINAL-02-07-18.pdf?la=en

Pharmaceuticals Inc. and Geisinger opens the door to a sweeping ...... Estate of Paul V. and Doris K. Rice ... Wyeth Pharmaceuticals ...... Theresa A. Chesney.

www.cell.com/molecular-therapy-family/oncolytics/fulltext/S2372-7705(16)30020-1

Vaccinia virus (Wyeth strain), JX-594 (pexastimogene devacirepvec, Pexa-Vec), Intratumoral, Three ..... to be 14.1 months for the high-dose receiving patients versus 6.7 months in the low-dose group. ...... Kaufman, HL; Andtbacka, RHI; Collichio, FA; Amatruda, T; Senzer, NN; Chesney, J; et al. ..... Published by Elsevier Inc.